Vaxcyte, Inc. PCVX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s cash ratio?
- Vaxcyte, Inc. (PCVX) reported cash ratio of 1.1× in Q1 2026.
- How has Vaxcyte, Inc.'s cash ratio changed year-over-year?
- Vaxcyte, Inc.'s cash ratio decreased by 69.8% year-over-year, from 3.6× to 1.1×.
- What is the long-term trend for Vaxcyte, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s cash ratio has grown at a -36.5% compound annual growth rate (CAGR), from 8.2× to 0.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.